Terms: = Breast cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Prognosis
2085 results:
1. The relationship of changes in molecular subtypes with metastases and progression-free survival in breast cancer.
Amansyah F; Prihantono P; Hamid F; Syamsu SA; Pieter J; Faruk M
Breast Dis; 2024; 43(1):71-78. PubMed ID: 38669518
[TBL] [Abstract] [Full Text] [Related]
2. [Role of neoadjuvant rectal score in prognosis and adjuvant chemotherapy decision-making in locally advanced rectal cancer following neoadjuvant short-course radiotherapy and consolidation chemotherapy].
Zeng Q; Tang Y; Zhou HT; Li N; Liu WY; Chen SL; Li S; Lu NN; Fang H; Wang SL; Liu YP; Song YW; Li YX; Jin J
Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):335-343. PubMed ID: 38644269
[No Abstract] [Full Text] [Related]
3. Analysis of 25 surgical cases of thymic neuroendocrine tumors and thymic carcinoma.
Midorikawa K; Miyahara S; Nishino N; Ueda Y; Waseda R; Shiraishi T; Sato T
J Cardiothorac Surg; 2024 Apr; 19(1):225. PubMed ID: 38627811
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological Significance of Tumor Budding in breast Carcinoma.
Buch A; Jain K; Rathod H; Gore C
J Nepal Health Res Counc; 2024 Mar; 21(3):417-427. PubMed ID: 38615212
[TBL] [Abstract] [Full Text] [Related]
5. Treatment Monitoring of a Patient with Synchronous Metastatic Angiosarcoma and breast cancer Using ctDNA.
Vannas C; Escobar M; Österlund T; Andersson D; Mouhanna P; Soomägi A; Molin C; Wennergren D; Fagman H; Ståhlberg A
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612833
[TBL] [Abstract] [Full Text] [Related]
6. Selective omission of sentinel lymph node biopsy in mastectomy for ductal carcinoma in situ: identifying eligible candidates.
Bae SJ; Kook Y; Jang JS; Baek SH; Moon S; Kim JH; Lee SE; Kim MJ; Ahn SG; Jeong J
Breast Cancer Res; 2024 Apr; 26(1):65. PubMed ID: 38609935
[TBL] [Abstract] [Full Text] [Related]
7. Significance of Estrogen/Progesterone Receptor Expression in Metaplastic breast Carcinoma.
Hashmi AA; Mallick BA; Rashid K; Malik UA; Zia S; Zia F; Irfan M
Dis Markers; 2024; 2024():2540356. PubMed ID: 38601434
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic and clinicopathological value of systemic inflammation response index (SIRI) in patients with breast cancer: a meta-analysis.
Zhang S; Cheng T
Ann Med; 2024 Dec; 56(1):2337729. PubMed ID: 38569199
[TBL] [Abstract] [Full Text] [Related]
9. Survival in pregnancy-associated breast cancer patients compared to non-pregnant controls.
Cameán MM; Marin IJ; Mendez JIS; Alvarez CM; Alegre FB; Boado EM; Spagnolo E; Zapardiel I; Gutiérrez AH
Reprod Biol Endocrinol; 2024 Mar; 22(1):34. PubMed ID: 38532462
[TBL] [Abstract] [Full Text] [Related]
10. BIRC5 expression by race, age and clinical factors in breast cancer patients.
Hamilton AM; Walens A; Van Alsten SC; Olsson LT; Nsonwu-Farley J; Gao X; Kirk EL; Perou CM; Carey LA; Troester MA; Abdou Y
Breast Cancer Res; 2024 Mar; 26(1):50. PubMed ID: 38515208
[TBL] [Abstract] [Full Text] [Related]
11. [A Case of breast cancer That Developed Pulmonary Tumor Thrombotic Microangiopathy during Adjuvant Chemotherapy].
Okano K; Suzuki T; Abe A; Itaya A; Kameyama Y; Matsumoto S; Hakamada K
Gan To Kagaku Ryoho; 2024 Mar; 51(3):283-285. PubMed ID: 38494809
[TBL] [Abstract] [Full Text] [Related]
12. Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysis.
Nader-Marta G; Monteforte M; Agostinetto E; Cinquini M; Martins-Branco D; Langouo M; Llombart-Cusac A; Cortés J; Ignatiadis M; Torri V; Apolone G; Cappelletti V; Pruneri G; de Azambuja E; Di Cosimo S
ESMO Open; 2024 Mar; 9(3):102390. PubMed ID: 38460249
[TBL] [Abstract] [Full Text] [Related]
13. Correlation between postoperative treatment selection and prognosis determined using the Oncotype DX® test data: a retrospective multicenter study in Japan.
Tsuchida Y; Niikura N; Chishima T; Mizuno M; Kawate T; Fuchikami H; Miyoshi Y; Sakai T; Kotani H; Kondo N; Hayashi N
Breast Cancer; 2024 May; 31(3):401-408. PubMed ID: 38451415
[TBL] [Abstract] [Full Text] [Related]
14. A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies.
Conte B; Brasó-Maristany F; Hernández AR; Pascual T; Villacampa G; Schettini F; Vidal Losada MJ; Seguí E; Angelats L; Garcia-Fructuoso I; Gómez-Bravo R; Lorman-Carbó N; Paré L; Marín-Aguilera M; Martínez-Sáez O; Adamo B; Sanfeliu E; Fratini B; Falato C; Chic N; Vivancos A; Villagrasa P; Staaf J; Parker JS; Perou CM; Prat A
EBioMedicine; 2024 Apr; 102():105043. PubMed ID: 38447275
[TBL] [Abstract] [Full Text] [Related]
15. Risk factors and prognosis of sentinel lymph node metastasis in breast-conserving breast cancer: A retrospective study based on the SEER database.
Liu R; Chen J; Cao W; Li T; Liao Y; Li Y
Medicine (Baltimore); 2024 Mar; 103(9):e37263. PubMed ID: 38428869
[TBL] [Abstract] [Full Text] [Related]
16. SPC25 Functions as a Prognostic-Related Biomarker, and Its High Expression Correlates with Tumor Immune Infiltration and UCEC Progression.
Liao LX; Zhang M; Xu X; Zhang S; Guo YZ
Front Biosci (Landmark Ed); 2024 Feb; 29(2):69. PubMed ID: 38420826
[TBL] [Abstract] [Full Text] [Related]
17. ASSESSMENT OF CIRCULATING miRNA LEVELS IN breast cancer PATIENTS DEPENDING ON CLINICAL CHARACTERISTICS AND CHEMOTHERAPY.
Harashchenko О
Exp Oncol; 2024 Feb; 45(4):451-456. PubMed ID: 38328845
[TBL] [Abstract] [Full Text] [Related]
18. Intraventricular Cerebral Metastases: A Comprehensive Systematic Review.
Scalia G; Silven MP; Costanzo R; Porzio M; Maugeri R; Iacopino DG; Nicoletti GF; Umana GE
Anticancer Res; 2024 Feb; 44(2):453-462. PubMed ID: 38307552
[TBL] [Abstract] [Full Text] [Related]
19. Bidirectional Mendelian randomization analysis investigating the genetic association between primary breast cancer and colorectal cancer.
Liu Y; Si M; Qian Y; Liu Y; Wang Z; Zhang T; Wang Z; Ye K; Xiang C; Xu L; Zhang Y; Xiao Z
Front Immunol; 2023; 14():1260941. PubMed ID: 38283349
[TBL] [Abstract] [Full Text] [Related]
20. breast cancer Incidence Among US Women Aged 20 to 49 Years by Race, Stage, and Hormone Receptor Status.
Xu S; Murtagh S; Han Y; Wan F; Toriola AT
JAMA Netw Open; 2024 Jan; 7(1):e2353331. PubMed ID: 38277147
[TBL] [Abstract] [Full Text] [Related]
[Next]